Sr Manager, MSL - North Germany

Overview

The Medical Science Liaison is responsible for managing and executing field medical activities that support the Medical Affairs strategies for marketed products and/or development compounds. They use clinical knowledge and field expertise along with business orientation to identify and communicate scientific trends in the healthcare environment. They engage in peer coaching across the Field team and are sought out by peers and colleagues to inform the medical strategy with identified market and healthcare trends. The Medical Science Liaison will understand the external healthcare environment and data gaps related to the disease area or product; gather field intelligence, identify and communicate key insights to internal colleagues; and fulfill stakeholder information needs by communicating appropriate details of therapeutic area and product/compound. The ideal candidate will possess an understanding of rare and prevalent diseases development and a strong sense of science and business acumen.

Key Responsibilities

• Identify and engage with medical experts in therapeutic areas relevant for Alnylam and with healthcare professionals in general, establish and maintain peer-to-peer relationships to build awareness, to ensure proper product use and investigate potential new uses of Alnylam’s products
• Identify investigator-initiated study (IIS) opportunities ,andact as the primary conduit
• Report emerging clinical trends
• Assist in development of advisory boards, symposia and publication plans
• Support the Medical Director and/or Medical Affairs Manager to develop appropriate strategic and tactical plans (e.g. MAC) for the country/cluster and/or program
• Support the Medical Director and/or Medical Affairs Manager in the review of the promotional material of the country/cluster and/or program in local language
• Be the team expert on all aspects of the MSL role including: subject matter expertise, process improvements and sharing of best practice
• Collaboratively workwith Key Account Managers/Disease Awareness Representatives and Commercial colleagues to ensure strategies and business plans are both patient and business focused
• Work with the office-based medical affairs team to bring the voice of the field-based MSL into strategy development and material creation
• Provide accurate and fair-balanced medical and scientific education using the medical-scientific literature (summaries of publications, education and presentation scientific materials) and give presentations to health care professionals and internal stakeholders both proactively (respecting national laws, regulations and industry codes) and in response to requests for information.
• Provide scientific support and attendance to conferences and meetings
• Ensure relevant and appropriate responses to customer medical inquiries
• Maintain a high level of expertise in the evolving scientific / therapeutic area and in competitor medicines
• Be fully compliant with all Ethics, Compliance and other internal policies
• Report adverse events in due time according to company policy
  
  

Qualifications

• Degree in medical/natural sciences (Higher Degree is preferred).
• 2+ years of MSL experience within the health care industry preferred
• Excellent subject matter expertise
• Highest ethical standards
• Excellent interpersonal skills
• Excellent presentation skills
• Ability to analyse complext scientific materia
• Clinical trial experience with working knowledge of GCP is beneficial
• Training in reporting of adverse events
• Experience with literature review, synthesis and analysis
• Experience in public presentation required
• Time and territory management skills required
• Ability to organize and prioritize own work schedule
• Prior experience in managing a frequent travel schedule
• Approximately 50-60% travel is required; overnight travel is required as needed
  
  

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.